PUBLISHED 2017

(Webinar held: February 14, 2017) Learn more about the 2023 provisions to facilitate unit-level traceability across the U.S. supply chain, including changes in transaction data, trading partner obligations in the event of certain investigations, when verification is and is not mandated and how the statute addresses inference and aggregation.

The 2023 deadline for Drug Supply Chain Security Act (DSCSA)-mandated, unit-level traceability is only six years away, as are the law’s enhanced distribution security requirements. Learn more about the 2023 provisions to facilitate unit-level traceability across the U.S. supply chain, including changes in transaction data, trading partner obligations in the event of certain investigations, when verification is and is not mandated and how the statute addresses inference and aggregation.

This webinar is sponsored by Axway.

Panelists:
Anita Ducca, Senior Vice President, Regulatory Affairs, Healthcare Distribution Alliance
Elizabeth Gallenagh, Esq., Senior Vice President, Government Affairs and General Counsel, Healthcare Distribution Alliance
Tish Pahl, Principal, Olsson Frank Weeda Terman Matz PC
Brian Waldman, Partner, Arent Fox LLP